Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population

por Ørsted, David Dynnes, Bojesen, Stig Egil, Tybjærg-Hansen, Anne, Nordestgaard, Børge Grønne
Publicado 2007

LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

por Rutten, Guy E. H. M., Tack, Cees J., Pieber, Thomas R., Comlekci, Abdurrahman, Ørsted, David Dynnes, Baeres, Florian M. M., Marso, Steven P., Buse, John B.
Publicado 2016